EBS:NYSE
Emergent Biosolutions Inc
7,16 USD
arrow_upward
+1,42%(+0,100) 1 D
12. okt., 12:07:45 GMT-4 · USD
search
Alle symboler
| Symbol | Pris | Endring | Endring (%) |
|---|
insights_autoGenererer viktig statistikk for EBS …
Åpne
7,08 USD
Høy
7,33 USD
Lav
7,00 USD
Markedsverdi
367,12 mill.
Snittvolum
1,16 mill.
Volum
431,21k
52 u høy
14,06 USD
52 u lav
4,36 USD
EPS
−3,51 USD
Beta
2,28
Utestående aksjer
51,27 mill.
Antall ansatte
900
Åpne
7,08 USD
Høy
7,33 USD
Lav
7,00 USD
Markedsverdi
367,12 mill.
Snittvolum
1,16 mill.
Volum
431,21k
52 u høy
14,06 USD
52 u lav
4,36 USD
EPS
−3,51 USD
Beta
2,28
Utestående aksjer
51,27 mill.
Antall ansatte
900
Nyhetssaker
Fra nettkilder og nyhetspartnere
Invezz
·
for 2 døgn siden
Dow stiger 423 poeng etter teknologireprise, telekomaksjer faller på SpaceX
Invezz
·
for 3 timer siden
Topp 3 katalysatorer for S&P 500-indeksen denne uken: obligasjoner, kvartalstall, KPI
PR Newswire
·
for 10 minutter siden
Fluence Energy (NASDAQ: FLNC) Faces Securities Class Action Amid Inability to Ramp Houston Facility - HBSS
IndexBox
·
for 9 minutter siden
S&P 500 Record High Masks US Household Financial Strain
Profil
Emergent BioSolutions Inc. is an American multinational specialty biopharmaceutical company headquartered in Gaithersburg, Maryland. It develops vaccines and antibody therapeutics for infectious diseases and opioid overdoses, and it provides medical devices for biodefense purposes.
Among the company's products are the controversial BioThrax, the only anthrax vaccine licensed by the U.S. Food and Drug Administration and Narcan for the emergency treatment of opioid overdose. The company also manufactures pharmaceuticals for infectious diseases like cholera and typhoid.
During the COVID-19 pandemic, Emergent BioSolutions also produced Johnson & Johnson/Janssen and Oxford–AstraZeneca vaccines at one of its plants; however, this was marked by contamination and other production issues, and millions of doses of vaccine had to be discarded. Wikipedia
Om Emergent Biosolutions Inc
Administrerende direktørRobert G. Kramer Sr. | Joseph C. Papa
Ansatte900
Grunnlagt5. sep. 1998
HovedkontorRockville, Maryland, USA
Sektor-
Nettstedemergentbiosolutions.com